Jianqiang Ye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianqiang Ye has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Roberto Perez
Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA, USA
1 shared publication - Haichen Song
Synbiotics Co. 8075 Greenmead Drive, College Park, MD 20742-3711, USA
1 shared publication - Hongxia Shao
Department of Veterinary Medicine, University of Maryland, College Park, 8075 Greenmead Drive, College Park, MD 20742-3711, USA
1 shared publication - Rangarajan Padmanabhan
Department of Animal and Avian Sciences, University of Maryland College Park, 1413 Animal Sciences Center, College Park, MD 20742-2311, USA
1 shared publication - Troy C Sutton
Department of Veterinary Medicine, University of Maryland, College Park, and Virginia-Maryland College of Veterinary Medicine, Maryland Campus, College Park, Maryland, USA
1 shared publication - Yibin Cai
Department of Veterinary Medicine, University of Maryland, College Park, 8075 Greenmead Drive, College Park, MD 20742-3711, USA
1 shared publication
Latest Publications
- Open Access
- 21 January 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 31
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
Mass in ovo vaccination with live attenuated viruses is widely used in the poultry industry to protect against various infectious diseases. The worldwide outbreaks of low pathogenic and highly pathogenic avian influenza highlight the pressing need for the development of similar mass vaccination strategies against avian influenza viruses. We have previously shown that a genetically modified live attenuated avian influenza virus (LAIV) was amenable for in ovo vaccination and provided optimal protection against H5 HPAI viruses. However, in ovo vaccination against other subtypes resulted in poor hatchability and, therefore, seemed impractical. In this study, we modified the H7 and H9 hemagglutinin (HA) proteins by substituting the amino acids at the cleavage site for those found in the H6 HA subtype. We found that with this modification, a single dose in ovo vaccination of 18-day old eggs provided complete protection against homologous challenge with low pathogenic virus in ≥70% of chickens at 2 or 6 weeks post-hatching. Further, inoculation of 19-day old egg embryos with 106 EID50 of LAIVs improved hatchability to ≥90% (equivalent to unvaccinated controls) with similar levels of protection. Our findings indicate that the strategy of modifying the HA cleavage site combined with the LAIV backbone could be used for in ovo vaccination against avian influenza. Importantly, with protection conferred as early as 2 weeks post-hatching, with this strategy birds would be protected prior to or at the time of delivery to a farm or commercial operation.
- 21 January 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 31
Open AccessImproved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
Mass in ovo vaccination with live attenuated viruses is widely used in the poultry industry to protect against various infectious diseases. The worldwide outbreaks of low pathogenic and highly pathogenic avian influenza highlight the pressing need for the development of similar mass vaccination strategies against avian influenza viruses. We have previously shown that a genetically modified live attenuated avian influenza virus (LAIV) was amenable for in ovo vaccination and provided optimal protection against H5 HPAI viruses. However, in ovo vaccination against other subtypes resulted in poor hatchability and, therefore, seemed impractical. In this study, we modified the H7 and H9 hemagglutinin (HA) proteins by substituting the amino acids at the cleavage site for those found in the H6 HA subtype. We found that with this modification, a single dose in ovo vaccination of 18-day old eggs provided complete protection against homologous challenge with low pathogenic virus in ≥70% of chickens at 2 or 6 weeks post-hatching. Further, inoculation of 19-day old egg embryos with 106 EID50 of LAIVs improved hatchability to ≥90% (equivalent to unvaccinated controls) with similar levels of protection. Our findings indicate that the strategy of modifying the HA cleavage site combined with the LAIV backbone could be used for in ovo vaccination against avian influenza. Importantly, with protection conferred as early as 2 weeks post-hatching, with this strategy birds would be protected prior to or at the time of delivery to a farm or commercial operation.